Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
letter
. 1979 Nov;71(11):1101–1105.

Intravenous Iron-Dextran in the Treatment of Iron Deficient Anemia

Cage S Johnson
PMCID: PMC2537535  PMID: 529311

Abstract

Administration of oral ferrous salts is the preferred method of treatment for anemia due to iron deficiency. However, in certain clinical situations, the response to oral therapy may be suboptimal. Parenteral iron therapy is effective in these instances and may produce a faster response than the oral route.

Of 30 patients treated by total dose intravenous infusion of iron-dextran, a prompt reticulocytosis occurred in all patients except one case associated with systemic lupus erythematosus. Hematologic improvement in this case followed remission of the systemic lupus erythematosus. Hematologic response was complete in 18 patients in five to nine weeks, but could not be evaluated in 11 cases because of recurrent bleeding. There were two adverse reactions: generalized pruritus after injection in one patient, and superficial thrombophlebitis at the injection site of another.

The response to therapy in iron deficient anemia is dependent on bone marrow capacity, the severity of the anemia, and the availability of iron. Response was fastest in those who had been severely anemic for prolonged periods of time. Total dose infusion with iron-dextran is a safe and effective treatment for iron deficient anemia in selected cases. Initial response appears to be faster than that on oral therapy with the exception of those with a mild degree of anemia.

Full text

PDF
1101

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BASU S. K. ADMINISTRATION OF IRON DEXTRAN COMPLEX BY CONTINUOUS INTRAVENOUS INFUSION. J Obstet Gynaecol Br Commonw. 1965 Apr;72:253–258. doi: 10.1111/j.1471-0528.1965.tb01426.x. [DOI] [PubMed] [Google Scholar]
  2. BEUTLER E., DRENNAN W., BLOCK M. The bone marrow and liver in iron-deficiency anemia; a histopathologic study of sections with special reference to the stainable iron content. J Lab Clin Med. 1954 Mar;43(3):427–439. [PubMed] [Google Scholar]
  3. Becker C. E., MacGregor R. R., Walker K. S., Jandl J. H. Fatal anaphylaxis after intramuscular iron-dextran. Ann Intern Med. 1966 Oct;65(4):745–748. doi: 10.7326/0003-4819-65-4-745. [DOI] [PubMed] [Google Scholar]
  4. Benito R. P., Guerrero T. C. Response to a single intravenous dose versus multiple intramuscular administration of iron-dextran complex: a comparative study. Curr Ther Res Clin Exp. 1973 Jul;15(7):373–382. [PubMed] [Google Scholar]
  5. COLEMAN D. H., STEVENS A. R., Jr, FINCH C. A. The treatment of iron deficiency anemia. Blood. 1955 Jun;10(6):567–581. [PubMed] [Google Scholar]
  6. COPE E., GILLHESPY R. O., RICHARDSON R. W. Treatment of iron-deficiency anaemia; comparison of methods. Br Med J. 1956 Sep 15;2(4993):638–640. doi: 10.1136/bmj.2.4993.638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hillman R. S., Henderson P. A. Control of marrow production by the level of iron supply. J Clin Invest. 1969 Mar;48(3):454–460. doi: 10.1172/JCI106002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jacobs J. Death due to iron parenterally. South Med J. 1969 Feb;62(2):216–passim. doi: 10.1097/00007611-196902000-00022. [DOI] [PubMed] [Google Scholar]
  9. MCCURDY P. R. ORAL AND PARENTERAL IRON THERAPY: A COMPARISON. JAMA. 1965 Mar 8;191:859–862. doi: 10.1001/jama.1965.03080100077026. [DOI] [PubMed] [Google Scholar]
  10. O'SULLIVAN D. J., HIGGINS P. G., WILKINSON J. F. Oral iron compounds; a therapeutic comparison. Lancet. 1955 Sep 3;269(6888):482–485. doi: 10.1016/s0140-6736(55)93333-x. [DOI] [PubMed] [Google Scholar]
  11. PRITCHARD J. A., MASON R. A. IRON STORES OF NORMAL ADULTS AND REPLENISHMENT WITH ORAL IRON THERAPY. JAMA. 1964 Dec 7;190:897–901. doi: 10.1001/jama.1964.03070230033008. [DOI] [PubMed] [Google Scholar]
  12. PRITCHARD J. A. The response to iron in iron deficiency. Anemia due to gynecologic disease. JAMA. 1961 Feb 11;175:478–482. doi: 10.1001/jama.1961.03040060052011. [DOI] [PubMed] [Google Scholar]
  13. Pritchard J. A. Hemoglobin regeneration in severe iron-deficiency anemia. Response to orally and parenterally administered iron preparations. JAMA. 1966 Feb 28;195(9):717–720. [PubMed] [Google Scholar]
  14. Robertson A. G., Dick W. C. Intramuscular iron and local oncogenesis. Br Med J. 1977 Apr 9;1(6066):946–946. doi: 10.1136/bmj.1.6066.946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. SWAN H. T., JOWETT G. H. Treatment of iron deficiency with ferrous fumarate. Assessment by a statistically accurate method. Br Med J. 1959 Oct 24;2(5155):782–787. doi: 10.1136/bmj.2.5155.782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wallerstein R. O. Intravenous iron-dextran complex. Blood. 1968 Oct;32(4):690–695. [PubMed] [Google Scholar]
  17. Zipf R. E., Jr Fatal anaphylaxis after intravenous iron dextran. J Forensic Sci. 1975 Apr;20(2):326–333. [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES